## Gene Summary
TRPM6 (Transient Receptor Potential Cation Channel Subfamily M Member 6) is a gene that encodes a member of the melastatin-related transient receptor potential (TRPM) subfamily of ion channels. TRPM6 is vital for magnesium ion uptake and homeostasis in the body. It primarily functions as a channel for divalent cations, especially magnesium, and is found co-expressed with TRPM7 in tissues like the kidney and the intestinal epithelium, which are critical sites for magnesium absorption. Defects in TRPM6 expression or function can significantly impact magnesium balance and overall cellular function.

## Gene Drugs, Diseases, Phenotypes, and Pathways
Mutations or dysfunction in TRPM6 have been directly linked to hypomagnesemia with secondary hypocalcemia (HSH), a rare inherited condition. This disorder is characterized by extremely low levels of magnesium in the blood, which can cause muscle spasms, seizures, and other neurological symptoms due to associated low calcium levels. Furthermore, TRPM6's role in magnesium handling connects it to broader physiological systems and influences pathways related to electrolyte balance, neuron function, and potentially to cardiovascular health given the general roles of magnesium in the body.

## Pharmacogenetics
While TRPM6 itself is not a direct target of many conventional drugs, its pharmacogenetic profile is critical in the context of magnesium supplementation and management therapies. For conditions like HSH, where TRPM6 mutations reduce magnesium absorption, patients often require high doses of oral magnesium salts to manage their symptoms. The effectiveness and necessity of such supplementation can depend on the particular mutations in the TRPM6 gene, highlighting its importance in personalized medicine approaches for managing electrolyte imbalances. Understanding the genetic underpinnings related to TRPM6 can guide treatment decisions in clinical settings, especially in determining appropriate magnesium supplementation levels.